Hum. Reprod. Advance Access originally published online on August 5, 2005
Human Reproduction 2005 20(12):3307-3312; doi:10.1093/humrep/dei235
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report
Department of Obstetrics and Gynecology, Divisions of Reproductive Endocrinology/Infertility and Maternal Fetal Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
1 To whom correspondence should be addressed at: amilki{at}stanford.edu
Thromboembolic phenomena are a serious consequence of assisted reproductive technology. We present a case of upper extremity deep vein thrombosis (DVT) at 7 weeks gestation following ovarian hyperstimulation syndrome (OHSS) and IVF. Three weeks after recovering from OHSS, the patient presented with left neck pain and swelling. Ultrasound revealed a thrombus in the left jugular vein and left subclavian vein. Low molecular weight heparin (LMWH) was initiated with symptom resolution within 1 week. The patient remained on LWMH throughout her pregnancy and delivered at term. A literature review showed 97 published cases of thromboembolism following ovulation induction. A majority of these cases was associated with OHSS and pregnancy and the site of involvement was predominantly in the upper extremity and neck. Infertility physicians and obstetricians should be aware of this complication and keep in mind that it may occur weeks after resolution of OHSS symptoms.
Key words: IVF/ovarian hyperstimulation/subclavian vein thrombosis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. M. Nelson and I. A. Greer The potential role of heparin in assisted conception Hum. Reprod. Update, November 1, 2008; 14(6): 623 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Cobbe Why the apparent haste to clone humans? J. Med. Ethics, May 1, 2006; 32(5): 298 - 302. [Full Text] [PDF] |
||||

